Tempest Therapeutics, Inc. · NASDAQ:TPST
Tempest Therapeutics, Inc. shareholders
As of Sep 30, 2026, 21 institutions reported holding Tempest Therapeutics, Inc., 2.7% of its shares. Largest: Vanguard, Geode Capital and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Tempest Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 314K | 1.6% | +11,672 | Nov 16, 2026 |
| Geode Capital | 74,076 | 0.37% | −12,549 | Nov 6, 2026 |
| BlackRock | 39,068 | 0.20% | no change | Nov 13, 2026 |
| UBS | 25,170 | 0.13% | +19,534 | Nov 10, 2026 |
| Hrt Financial LP | 21,315 | 0.11% | new | Nov 13, 2026 |
| Northern Trust | 20,136 | 0.10% | no change | Nov 16, 2026 |
| Citigroup Inc | 15,426 | 0.08% | new | Nov 4, 2026 |
| StoneX Group Inc. | 13,668 | 0.07% | new | Nov 3, 2026 |
| TRB Wealth Management, LLC | 10,846 | 0.05% | new | Nov 16, 2026 |
| Nuveen | 5,958 | 0.03% | new | Nov 10, 2026 |